đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
The primary objectives of this study are to evaluate the safety, tolerabili...
Status
Completed
Location
Gemeinschaftspraxis Dres. Adelt, Mettlich-Lambrecht und Denneberg ( Site 0053)
Start Date
2022-03-25
Trial ID
NCT05289271
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and immun...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00551915
Treatments Being Tested
The primary objectives of this study are to evaluate the immunogenicity and...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-30
Trial ID
NCT01553279
Treatments Being Tested
This study will determine whether three manufacturing lots of V419 (PR5I) i...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-10
Trial ID
NCT01340937
Treatments Being Tested
This study will determine whether participants who receive V419 (PR5I) at 2...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-23
Trial ID
NCT01480258
Treatments Being Tested